Actively Recruiting
Hypertonic Lactate After Cardiac Arrest
Led by Erasme University Hospital · Updated on 2025-02-21
125
Participants Needed
1
Research Sites
168 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
CONDITIONS
Official Title
Hypertonic Lactate After Cardiac Arrest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years old
- Sustained (> 20 minutes) return of spontaneous circulation (ROSC)
- Comatose (Glasgow Coma Scale < 9)
- Time to ROSC > 15 minutes
You will not qualify if you...
- Pregnant women
- Anticipated withdrawal of support within 24 hours
- Cardiac arrest caused by trauma
- Body weight at admission > 120 kilograms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasme Hospital, Brussels University Hospital (HUB)
Brussels, Belgium, Belgium, 1070
Actively Recruiting
Research Team
F
Filippo Annoni, MD
CONTACT
F
Fabio S Taccone, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here